Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Medisix Therapeutics
company
About
Medisix Therapeutics is a provider of immune engineering company developing novel cellular therapies.
- Singapore,Central Region,Singapore
- 1 - 10
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $20M
- Industries
- Biotechnology,Chemical Engineering,Life Science
- Founded date
- Jan 1, 2018
- Number Of Employee
- 1 - 10
- Operating Status
- Active
- Legal Name
- MediSix Therapeutics, Inc.
Medisix Therapeutics is a Singapore-based immune engineering company developing novel cellular therapies to address T cell malignancies. Their technology platform originates from world expert in translational immunology, Professor Dario Campana, MD, PhD, a physician scientist who pioneered chimeric antigen receptor T cell (CAR-T) biology. Their programs utilize proprietary immune engineering approaches that enable T cell leukemias and lymphomas to be targeted with cell therapy.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$20M
Medisix Therapeutics has raised a total of
$20M
in funding over 2 rounds. Their latest funding was raised on
May 15, 2018 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 15, 2018 | Series A | $20M | 3 |
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
3
Medisix Therapeutics is funded by 3 investors.
Lightstone Ventures
and OUP (Osage University Partners)
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Series A |
|
|
— | Series A |
Temasek Holdings
|
— | Series A |
Employee Profiles
Number of Employee Profiles
1
Medisix Therapeutics has 1 current employee profiles, including
Executive Dario Campana
Executive
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
